semaglutide compound vial Compounded Compounded Semaglutide (GLP-1)
Description
95% CI [7.6, 5.2]
.webp)
Behav Brain Res (2012) 232(1):15964
2022 Dec 1;4:100047
The FDA said that they have received 136 reports of adverse events occurring in people using compounded GLP-1 drugs containing tirzepatide for weight loss
Endocrinology and metabolism 295, E13231332, doi: 10.1152/ajpendo.90617.2008 (2008)
5 Dysesthesia (a skin sensation often described as tingling, numbness, or burning) affected around 21% of people on the 12 mg dose in TRIUMPH-4
